News

Kurt Petersen Ph.D. joins SnapDNA technical advisor board

Kurt Petersen received his BS degree cum laude in EE from UC Berkeley in 1970.  In 1975, he received a PhD in EE from the Massachusetts Institute of Technology.  Dr. Petersen established a micromachining research group at IBM from 1975 to 1982, during which he wrote the review paper “Silicon as a Mechanical Material,” published in the IEEE Proceedings (May 1982).  This paper is still the most frequently referenced work in the field of micromachining and micro-electro-mechanical systems (MEMS).

Since 1982, Dr. Petersen has co-founded six successful companies in MEMS technology, Transensory Devices Inc. in 1982, NovaSensor in 1985 (now owned by Amphenol), Cepheid in 1996 (now a public company on NASDAQ: CPHD), SiTime in 2004 (acquired by MegaChips in Japan), Profusa in 2008 (still private), and Verreon in 2009 (acquired by Qualcomm). 

In 2011, Dr. Petersen joined the Silicon Valley Band of Angels.  The Band is an angel investment group which mentors and invests in early stage, high-tech, start-up companies.  Today, he spends most of his time helping and mentoring such companies.

Dr. Petersen has published over 100 papers, and has been granted over 35 patents in the field of MEMS.  In 2001 he was awarded the IEEE Simon Ramo Medal for his contributions to MEMS.  Dr. Petersen is a member of the National Academy of Engineering and is a Life Fellow of the IEEE in recognition of his contributions to “the commercialization of MEMS technology”.

News

Jaleh Daie Ph.D. joins SnapDNA board of directors

SnapDNA announces Jaleh Daie as a board member
June 2, 2016

Women in Technology Hall of Famer and recipient of a US Congressional Citation, Dr. Jaleh Daie is a multifaceted and strategic leader with extensive board and executive experience in private and public sectors.  A noted plant biologist and leading agriculture/food expert, Jaleh understands capital markets and has global and cultural acumen (collaborations in eight countries and global speeches including the Biotech Distinguished Speaker in South Africa and Distinguished Visitor Speaker in Australia. She has had the honor of serving the administrations of three Presidents and has been quoted/interviewed by major media (ABC, CBS, PBS, NY Times, SV Business Journal, SF Chronicle, Science, and The Scientist). Jaleh has extensive board experience, delivering: insight, foresight and oversight. She has served as board chairman, on executive committees, treasurer, chair of nomination and investment committees and Gala Chair. Her recent board service includes SnapDNA, A6 Corp, Nokia Innovent, Investigen, Linkore, LightFull Foods, Selection Panel for the White House Fellows (under two Presidents); President of the Association for Women in Science and chairman of the Council of Scientific Society Presidents, CRDF Global; Commonwealth Club of California; Treasurer and life director of US Space Foundation; Dean’s Council at UC-Davis College of Agriculture.

Currently, Jaleh is managing partner at Aurora Equity, investing in early stage start-ups across a broad range of technologies, resulting in attractive ROI in the first 10 years. Previously, Jaleh was head of science at the David & Lucile Packard Foundation (the largest foundation then) where she managed a diversified portfolio with $120 million annual budget. She has served as science liaison to the President’s National Science & Technology Council (cabinet level body) working across all federal S&T agencies. She made contributions to Presidential initiatives including food safety and served as special assistant to Chief Scientist at NOAA.

Jaleh began her career at Rutgers University and UW-Madison (over 20 years).

In academia she was professor (achieved rank of professor in six years); senior science advisor to the President (26 campus UW System); department chair; initiated and led spin off of new multidisciplinary unit and served as its chief executive, and was founding director of a university-wide graduate program. In addition to running an internationally recognized research operation, at one point Jaleh was managing three independent operations–for one of which she was the conceptual architect and another was the outcome of her initiating and driving the strategic integration and consolidation of several legacy units.

Examples of Jaleh’s honors are: Life Science Queensland Ambassador, Honorary Naval Aviator, Teksia Lifetime Achievement Award; Honorary Doctorate; Fellow (American Association for the Advancement of Science and AWIS); “25 Smartest Who Make a Difference” and The Scientist’s “Leaders of Science”.

News

Bio-NEMS Corporation* Announces Strategic Partnership with In-Q-Tel

*SnapDNA Corporation was formerly known as Bio-NEMS Corporation

Bio-NEMS Corporation announced a strategic partnership and technology development agreement with In-Q-Tel (IQT) to accelerate commercialization of its rapid handheld DNA testing technology.  IQT, based in Arlington, VA, is the independent strategic investment firm that identifies, adapts, and delivers technologies that support the missions of the U.S. Intelligence Community.

Bio-NEMS has developed proprietary, interdisciplinary innovations to enable DNA to be directly analyzed on the surface of a semiconductor device.  This breakthrough capability is expected to enable DNA analysis in 5 minutes or less from a battery-powered device that can be operated by almost anyone.

“Our semiconductor-based approach enables low cost, digital accurate analysis for even the most challenging DNA/RNA applications such as human identification, oncology, non-invasive prenatal diagnostics and epigenetics,” says David Medin, CEO.  “This technology has the potential to revolutionize law enforcement, security and medical diagnostics.  The In-Q-Tel investment will help us to accelerate the commercialization of this much needed technology.”

“The semiconductor-based technology being developed by Bio-NEMS  represents a step forward in the field of DNA and RNA analysis,” said Syd Ulvick, Senior Vice President in charge of Physical and Biological Technologies at IQT.  “IQT is excited to help facilitate its continued development for both the commercial and government markets.”

About Bio-NEMS

Bio-NEMS is an emerging technology company based in Menlo Park, CA.  The company has proprietary, interdisciplinary innovations to enable DNA to be directly analyzed on the surface of a high-speed, custom semiconductor device.  The DNA sequencing market achieved a 1000-fold decrease in cost and analysis time by replacing electrophoresis-based analysis with semiconductor-based analysis.  Bio-NEMS is expected to be the first company to use semiconductor-based analysis to drive DNA testing into the portable realm.  For more information visit www.snapdna.com.

About IQT

In-Q-Tel is the not-for-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community.  Launched in 1999 as a private, independent organization, IQT’s mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States.  For more information, visitwww.iqt.org.